Lessons from COVID-19 Over the Spring
The COVID-19 pandemic is still here – with growing concerns in China and an evolving conversation over the future of vaccine strategy
The COVID-19 pandemic is still here – with growing concerns in China and an evolving conversation over the future of vaccine strategy
Malaria remains a disease of global concern, compounded by the global climate crisis. Efforts to eliminate and control it must accelerate.
The public reaction and global response to pandemics shows social patterns that are hard to ignore – and can illuminate future efforts to control disease
The COVID pandemic continues – with outbreaks around the world, but reactions vary. New challenges rise as people to seek to move on.
COVID-19 infections rebound in the West, while China faces its biggest outbreak since 2019. Amid these worries, pharma continues innovation.
The pandemic has forced a revision of pharmacovigilance, its role in industry and society. We examine lessons learned for the future.
In a bid to pre-empt novel variants, the search for COVID-19 treatments and vaccines continues unabated – with over 100 trials on-going.
We explore the impact of COVID-19 on clinical trials, their design and organization – with a particular focus on diversity and how that can be improved.
COVID-19 leaves long-lasting effects behind after acute disease – many of these include significant cardiovascular disease risks.
We explore the possible neuropathogenesis arising from acute and chronic COVID-19 disease – and the research currently investigating the field.
A weekly update on new research on COVID and the evolving policy situation in response to Omicron.
Omicron shows strong signs of abating in areas affected early in the wave. New research and understandings promise better responses in the future.
Examining the growing concerns of antibiotic resistance, and the lack of development and monetization issues in discovering novel antibiotics.
As the Omicron waves unfold throughout the globe, we find new lessons in policy and disease control, and pharmaceutical innovations.
A brief summary of understandings gleaned regarding the Omicron variant for the week leading up to 20 Dec 2021.
The Omicron variant of SARS-CoV-2 continues to spread throughout the developed and developing world alike, as questions remain over vaccines.
An update on the Omicron Variant of Concern of SARS-CoV-2 and the societal and industrial action needed to anticipate the evolution of COVID-19
A brief summary of the factors affecting the evolution of SARS-CoV-2 and the medical and societal conditions that enable it.
A review of the effects of the pandemic on clinical trial operations, and the rise of decentralised clinical trials as a consequence
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings